Myanmar delegates tour Penang for healthcare travel, in conjunction with the launch of Air Asia’s new Penang-Yangon route. The event ran in conjunction with the launch of Air Asia’s new Penang-Yangon route, available as of today increasing Malaysia’s accessibility for Myanmar healthcare travellers seeking treatment in the country.
SA-BRC announces the release of its report on "Global Skincare Devices Market Assessment & Forecast 2015 - 2019." Cryobased skincare technologies are anticipated to grow the fastest between 2015 and 2019 at a CAGR of 12.2%. In 2014, the market was valued at US$ 445.2 million.
Travelucion have signed a new deal to promote a wide range of treatments in Cuba to North Americans. Combination of low cost treatment and post-operative rehabilitation centres make Cuba an attractive location to American and Canadian medical tourists.
Medical Departures has raised a series A funding round worth US$2.5 million, the company announced today. The round was led by Singapore-based venture capital firm Digital Media Partners (DMP), and was joined by VC CyberAgent Ventures, European media firm Hubert Burda Media, and OPT SEA, the Southeast Asia arm of Japanese digital advertising agency OPT Group.
Malaysia Healthcare Travel Council (MHTC) and GD Assist Limited (GD Assist) are jointly organizing health consultation sessions by renowned specialists from Malaysia throughout the year 2016.The first session was by Dr. Ambikai Balan Sothinathan, consultant of urologist from Pantai Hospital, Malaysia.
Health-tech startup BookDoc, which sealed a record seed funding round led by a member of the Brunei Royal Family in January, has brought on board seasoned healthcare professionals to its core management team.
(PRWEB) MARCH 18, 2016 – Bioscience Americas, LLC (http://www.bioscienceamericas.com), a leading international developer of autologous stem cell therapy centers for the treatment of autoimmune diseases, is pleased to announce that its lead scientific researcher, Dr. Anand Srivastava, has been invited to speak at the Fifth Annual European Biosimilar Conference to be held in Valencia, Spain, June 27-29, 2016.